Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Mar Drugs ; 19(8)2021 Aug 05.
Article in English | MEDLINE | ID: mdl-34436289

ABSTRACT

Ulva lactuca (U. lactuca) is a green alga distributed worldwide and used as a food and cosmetic material. In our previous study, we determined the effects of U. lactuca methanol extracts on the UVB-induced DNA repair. In the present study, we fractionated U. lactuca methanol extracts to identify the effective compound for the DNA repair. MTT assay demonstrated that (+)-epiloliolide showed no cytotoxicity up to 100 µM in BJ-5ta human dermal fibroblast. Upon no treatment, exposure to UVB 400 J/m2 decreased cell viability by 45%, whereas (+)-epiloliolide treatment for 24 h after UVB exposure significantly increased the cell viability. In GO and GESA analysis, a number of differentially expressed genes were uniquely expressed in (+)-epiloliolide treated cells, which were enriched in the p53 signaling pathway and excision repair. Immunofluorescence demonstrated that (+)-epiloliolide increased the nuclear localization of p53. Comet assay demonstrated that (+)-epiloliolide decreased tail moment increased by UVB. Western blot analysis demonstrated that (+)-epiloliolide decreased the levels of p-p53, p21, Bax, and Bim, but increased that of Bcl-2. Reverse transcription PCR (RT-PCR) demonstrated that (+)-epiloliolide decreased the levels of MMP 1, 9, and 13, but increased that of COL1A1. These results suggest that (+)-epiloliolide regulates p53 activity and has protective effects against UVB.


Subject(s)
Benzofurans/pharmacology , Fibroblasts/drug effects , Skin Aging , Tumor Suppressor Protein p53/drug effects , Ulva , Aquatic Organisms , Humans , Phytotherapy , Ultraviolet Rays
2.
J Complement Integr Med ; 17(1)2019 Dec 21.
Article in English | MEDLINE | ID: mdl-31865288

ABSTRACT

Background This study was designed to examine the effectiveness of program combining chakrayoga and meditation on the physical health and disease-related factors and psychological factors of people. Methods Ninety-seven subjects (32-83 years old) who had free from prior experiences in meditation programs or Chakrayoga training courses were assigned to either the experimental group (EXP) (45 subjects; 13 male subjects and 32 female subjects; average age of 60.67 years, SD=11.09 years) or the control group (CONT) of remaining subjects (52 subjects; 14 male subjects and 38 female subjects; average age of 61.58 years, SD=9.70 years). Subjects in the EXP participated in the Chakrayoga Meditation Program for twice a week for 2 h during 6 weeks in each session consisted of 1 h of Chakrayoga and 1 h of meditation. The measurements in this study included the mindfulness, stress response, subjective quality of life, medical symptom checklist, difficulty in emotional regulation and objective of life and sense of control. Results Results revealed that participants in the EXP reported significantly more relief of mindfulness, stress response, subjective quality of life and medical symptom checklist than those in the CONT. Conclusions These findings provide evidence that the Chakrayoga Meditation Program can help relieve the physical health and disease-related factors and psychological factors.


Subject(s)
Behavioral Symptoms/therapy , Meditation/methods , Yoga , Adult , Aged , Aged, 80 and over , Anger , Depression , Emotions , Female , Humans , Male , Middle Aged , Mindfulness , Quality of Life , Stress, Psychological , Surveys and Questionnaires
3.
Int J Toxicol ; 26(2): 151-8, 2007.
Article in English | MEDLINE | ID: mdl-17454255

ABSTRACT

Ginseng has been used worldwidely as a traditional medicine of Asian countries for treatment of various diseases including cancer. The purpose of this study was to determine the effect of ginseng saponin mRg2, a mixture of ginsenosides containing 60% Rg2, on the repair and apoptosis of ultraviolet B (UVB)-exposed NIH3T3 cells. When cells were exposed to UVB and then incubated with normal growth medium for 48 h, cell viability, as determined by trypan blue exclusion assay decreased to about 25%. However, when mRg2 was included in the postincubation medium, the UVB-induced loss of cell viability was significantly reduced as compared with that postincubated in normal growth medium. 4,6-diamidino-2-phenylindole (DAPI) staining showed that postincubation of the UVB-exposed cells in medium containing mRg2 significantly reduced the apoptotic nuclear fragmentation. Interestingly, when cells were preincubated with mRg2 for 24 h and then exposed to various doses of UV, the amount of repair synthesis significantly increased as compared with those in cells exposed to UVB alone. Western blot analysis indicated that the mRg2 postincubation after UVB exposure potentiated the level of p53 and p21. The level of Triton nonextractable proliferating cell nuclear antigen (PCNA) also remained elevated by mRg2 postincubation. All these results suggest that mRg2 protects cells against UVB-induced genotoxicity by increasing DNA repair and decreasing apoptosis, in possible association with the modulation of protein levels involved in cell cycle arrest or progression.


Subject(s)
Apoptosis/drug effects , DNA Repair/drug effects , Ginsenosides/pharmacology , Radiation-Protective Agents/pharmacology , Animals , Apoptosis/radiation effects , Cell Survival/drug effects , Cell Survival/radiation effects , DNA Repair/radiation effects , Ginsenosides/chemistry , Mice , NIH 3T3 Cells , Panax/chemistry , Saponins/chemistry , Ultraviolet Rays
4.
Toxicol Appl Pharmacol ; 181(3): 192-202, 2002 Jun 15.
Article in English | MEDLINE | ID: mdl-12079428

ABSTRACT

In this study we investigated the effect of ginseng saponins on the p53-dependent apoptosis in NIH3T3 cells exposed to methyl methanesulfonate (MMS), an alkylating agent. Trypan blue exclusion assay, cell morphology studies, and apoptotic index determined by acridine orange staining showed that the postincubation of MMS-exposed cells in medium containing diol- (PD) or triol-type (PT) ginseng saponins potentiate the apoptotic cell death. FACS analysis indicated that the increased apoptotic cell population in the saponin-postincubation group was accompanied by the accumulation of cells in G0/G1 phase. By Western blot analyses it was demonstrated that postincubation of saponins increases the expression of p53 and p21 in MMS-exposed cells but decreased that of CDK2, cyclin E and D1, and PCNA. The upregulation of p53 and p21 and downregulation of CDK2 was shown to be p53-dependent in experiments using the p53 antisense oligonucleotide. These results suggest that ginseng saponins contain components potentiating the apoptosis of MMS-exposed NIH3T3 cells via p53 and p21 activation, accompanied with by downregulation of cell cycle-related protein expression.


Subject(s)
Apoptosis/drug effects , CDC2-CDC28 Kinases , Methyl Methanesulfonate/toxicity , Mutagens/toxicity , Panax/chemistry , Saponins/pharmacology , 3T3 Cells , Animals , Blotting, Western , Cell Cycle Proteins/metabolism , Cyclin-Dependent Kinase 2 , Cyclin-Dependent Kinases/metabolism , Drug Synergism , Flow Cytometry , Mice , Oligonucleotides, Antisense/pharmacology , Oncogene Protein p21(ras)/metabolism , Protein Serine-Threonine Kinases/metabolism , Saponins/chemistry , Tumor Suppressor Protein p53/metabolism
5.
J Biol Chem ; 277(10): 8346-53, 2002 Mar 08.
Article in English | MEDLINE | ID: mdl-11751921

ABSTRACT

A variety of surface receptors eliciting diverse cellular responses have been shown to recruit tumor necrosis factor receptor-associated factor (TRAF) adaptor molecules. However, a few TRAF-interacting intracellular proteins that serve as downstream targets or regulators of TRAF function have been identified. In search of new intracellular molecules that bind TRAF6, we carried out a yeast two-hybrid cDNA library screening with an N-terminal segment of TRAF6 as the bait. A novel human C(2)H(2)-type zinc finger family protein was identified, which when coexpressed with TRAF6 led to a suppression of TRAF6-induced activation of NF-kappa B and c-Jun N-terminal kinase. This novel protein was designated TIZ (for TRAF6-inhibitory zinc finger protein). TIZ expression also inhibited the signaling of RANK (receptor activator of NF-kappa B), which together with TRAF6 has been shown to be essential for osteoclastogenesis. Furthermore, the expression level of TIZ appeared to be regulated during the differentiation of human peripheral blood monocytes into osteoclasts. More significantly, transfection of TIZ into the monocyte/macrophage cell line Raw264.7 reduced the RANK ligand-induced osteoclastogenesis of this cell line. Our findings suggest that the novel zinc finger protein TIZ may play a role during osteoclast differentiation by modulating TRAF6 signaling activity.


Subject(s)
Carrier Proteins/biosynthesis , Carrier Proteins/chemistry , Osteoclasts/cytology , Osteoclasts/metabolism , Proteins/physiology , Transcription Factors , Zinc Fingers , Amino Acid Sequence , Animals , Carrier Proteins/metabolism , Cell Differentiation , Cell Line , Cloning, Molecular , DNA, Complementary/metabolism , Enzyme Activation , Gene Library , Glutathione Transferase/metabolism , Humans , JNK Mitogen-Activated Protein Kinases , Luciferases/metabolism , Macrophages/metabolism , Membrane Glycoproteins/metabolism , Mice , Microscopy, Confocal , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , NF-kappa B/metabolism , Protein Binding , Protein Structure, Tertiary , Proteins/metabolism , RANK Ligand , Receptor Activator of Nuclear Factor-kappa B , Recombinant Fusion Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , TNF Receptor-Associated Factor 6 , Time Factors , Two-Hybrid System Techniques
SELECTION OF CITATIONS
SEARCH DETAIL